Intrinsiqq
Eli Lilly and Company logo

Eli Lilly and Company Insider Trading

LLY

⊜ Compare
Last 12 months

Insiders sold $26.9M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Aug 2025.

Net open-market
−$26.9M
0 buys · 6 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
Aug 2025
Aug 15, 2025

Get an email when LLY's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 210b5-1 plan
    Anat Hakim
    EVP, GC & Secretary · sold 5,000 at $1,402.52
    $7.01M
    9.9% of stake
  • Aug 1710b5-1 plan
    Patrik Jonsson
    EVP & President, LLY Int'l · sold 6,500 at $1,175.10
    $7.64M
    11% of stake
  • Aug 1010b5-1 plan
    Donald A Zakrowski
    SVP, Finance, & CAO · sold 2,000 at $1,185.01
    $2.37M
    38% of stake
  • Aug 710b5-1 plan
    Anat Hakim
    EVP, GC & Secretary · sold 5,000 at $1,190.00
    $5.95M
    9.0% of stake
  • Jun 1010b5-1 plan
    Ilya Yuffa
    EVP&Pres, LLY USA&Global Capab · sold 2,500 at $1,150.77
    $2.88M
    7.7% of stake
  • May 6No plan
    Lilly Endowment INC
    Large holder · sold 15,828 at avg $995.36
    $15.8M
    <0.1% of stake
  • Jan 7No plan
    Lilly Endowment INC
    Large holder · sold 292,148 at avg $1,103.48
    $322M
    0.3% of stake
  • Jan 5No plan
    Lilly Endowment INC
    Large holder · sold 1,390 at $1,085.01
    $1.51M
    <0.1% of stake
  • Dec 29, 2025No plan
    Lilly Endowment INC
    Large holder · sold 3,593 at $1,085.04
    $3.9M
    <0.1% of stake
  • Dec 24, 2025No plan
    Lilly Endowment INC
    Large holder · sold 2,629 at $1,085.17
    $2.85M
    <0.1% of stake
  • Dec 23, 2025No plan
    Lilly Endowment INC
    Large holder · sold 240 at $1,085.04
    260K
    <0.1% of stake
  • Nov 25, 2025No plan
    Lilly Endowment INC
    Large holder · sold 15,632 at avg $1,109.30
    $17.3M
    <0.1% of stake
  • Nov 25, 2025No plan
    Lilly Endowment INC
    Large holder · sold 147,061 at avg $1,095.35
    $161M
    0.2% of stake
  • Nov 24, 2025No plan
    Lilly Endowment INC
    Large holder · sold 142,307 at avg $1,068.53
    $152M
    0.2% of stake
  • Nov 21, 2025No plan
    Lilly Endowment INC
    Large holder · sold 105,326 at avg $1,058.66
    $112M
    0.1% of stake
  • Nov 20, 2025No plan
    Lilly Endowment INC
    Large holder · sold 37,148 at avg $1,051.66
    $39.1M
    <0.1% of stake
  • Nov 19, 2025No plan
    Lilly Endowment INC
    Large holder · sold 167,526 at avg $1,051.17
    $176M
    0.2% of stake
  • Nov 18, 2025No plan
    Lilly Endowment INC
    Large holder · sold 60,213 at avg $1,034.78
    $62.3M
    <0.1% of stake
  • Nov 17, 2025No plan
    Lilly Endowment INC
    Large holder · sold 9,886 at avg $1,030.68
    $10.2M
    <0.1% of stake
  • Nov 14, 2025No plan
    Lilly Endowment INC
    Large holder · sold 178,295
    —
    0.2% of stake
  • Nov 13, 2025No plan
    Lilly Endowment INC
    Large holder · sold 46,606 at avg $1,030.26
    $48M
    <0.1% of stake
  • Nov 13, 202510b5-1 plan
    Donald A Zakrowski
    SVP, Finance, & CAO · sold 1,000 at $1,010.50
    $1.01M
    18% of stake
  • Nov 12, 2025No plan
    Lilly Endowment INC
    Large holder · sold 305,000 at avg $1,011.19
    $308M
    0.3% of stake
  • Nov 11, 2025No plan
    Lilly Endowment INC
    Large holder · sold 283,131 at avg $986.64
    $279M
    0.3% of stake
  • Nov 10, 2025No plan
    Lilly Endowment INC
    Large holder · sold 16,869 at avg $972.52
    $16.4M
    <0.1% of stake
  • Nov 5, 2025No plan
    Lilly Endowment INC
    Large holder · sold 40,432 at avg $951.56
    $38.5M
    <0.1% of stake
  • Nov 5, 2025No plan
    Lilly Endowment INC
    Large holder · sold 179,042 at avg $933.26
    $167M
    0.2% of stake
  • Nov 4, 2025No plan
    Lilly Endowment INC
    Large holder · sold 526 at $910.72
    479K
    <0.1% of stake
  • Nov 3, 2025No plan
    Lilly Endowment INC
    Large holder · sold 300,000 at avg $888.83
    $267M
    0.3% of stake
  • Oct 31, 2025No plan
    Lilly Endowment INC
    Large holder · sold 301,342 at avg $863.35
    $260M
    0.3% of stake
  • Oct 10, 2025No plan
    Lilly Endowment INC
    Large holder · sold 3,658 at avg $863.24
    $3.16M
    <0.1% of stake
  • Oct 9, 2025No plan
    Lilly Endowment INC
    Large holder · sold 10,602 at avg $852.49
    $9.04M
    <0.1% of stake
  • Oct 8, 2025No plan
    Lilly Endowment INC
    Large holder · sold 101,420 at avg $850.28
    $86.2M
    0.1% of stake
  • Oct 7, 2025No plan
    Lilly Endowment INC
    Large holder · sold 26,795 at $848.01
    $22.7M
    <0.1% of stake
  • Oct 6, 2025No plan
    Lilly Endowment INC
    Large holder · sold 161,183 at avg $850.22
    $137M
    0.2% of stake
  • Oct 3, 2025No plan
    Lilly Endowment INC
    Large holder · sold 192,404 at avg $837.93
    $161M
    0.2% of stake
  • Oct 2, 2025No plan
    Lilly Endowment INC
    Large holder · sold 112,596 at avg $821.55
    $92.5M
    0.1% of stake
  • Oct 1, 2025No plan
    Lilly Endowment INC
    Large holder · sold 215,822 at avg $821.47
    $177M
    0.2% of stake
  • Oct 1, 2025No plan
    Lilly Endowment INC
    Large holder · sold 135,193 at avg $794.15
    $107M
    0.1% of stake
  • Sep 30, 2025No plan
    Lilly Endowment INC
    Large holder · sold 113,694 at avg $763.40
    $86.8M
    0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch LLY, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with LLY

CompareIntrinsic value
JNJJohnson & Johnson
$276.34+3.82%53
MRKMerck & Co., Inc.
$150.36+3.93%41
ABBVAbbVie Inc.
$294.83+3.09%49
PFEPfizer Inc.
$30.79+2.63%30
BMYBristol-Myers Squibb Company
$64.20+4.04%61
ABTAbbott Laboratories
$115.55+5.62%25
UPCUniverse Pharmaceuticals Inc.
$1.47-1.34%39
TEVATeva Pharmaceutical Industries Ltd
$42.13+0.52%46

Held by ETFs

LLY is in 517 US ETFs. The largest of them, with LLY's weight in each:

Spot a number that looks wrong? Check it in LLY's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing LLY

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.